Evidence map›Paper›PMID 31993563›Full record

ArticleMayo Clinic proceedings. Innovations, quality & outcomes2019

Genome-wide Association Study of 24-Hour Urinary Excretion of Calcium, Magnesium, and Uric Acid.

Erin B Ware, Jennifer A Smith, Wei Zhao, Ron T Ganesvoort, Gary C Curhan, Martin Pollak, David B Mount, Stephen T Turner, Guotao Chen, Ronak Jagdeep Shah and 2 more

Open access · goldAbstract read
In one paragraph

Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Erin B WareSurvey Research Center, Institute for Social Research, University of Michigan, Ann Arbor.
Jennifer A SmithSurvey Research Center, Institute for Social Research, University of Michigan, Ann Arbor.
Wei ZhaoDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor.
Ron T GanesvoortDepartment of Internal Medicine, University of Groningen, Groningen, the Netherlands.
Gary C CurhanRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Martin PollakRenal Division, Beth Israel Deaconess Medical Center, Boston, MA.
David B MountRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Stephen T TurnerDivision of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Guotao ChenDepartment of Nephrology, The People's Hospital of Bishan District, Chongqing City, China.
Ronak Jagdeep ShahDivision of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Sharon L R KardiaDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor.
John C LieskeDivision of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
University of Michigan–Ann Arbor · USBrigham and Women's Hospital · USWinnMed · USBeth Israel Deaconess Medical Center · USMayo Clinic · USPeople's Hospital of Bishan District · CNUniversity of Groningen · NL

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Mayo Clinic Urology O'Brien Research CenterP50DK083007 · NIDDK · MAYO CLINIC ROCHESTER · PI LIESKE, JOHN C · 2008 to 2012
$5.3M
Genomic Predictors of Arteriosclerosis in HypertensivesR01HL087660 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KARDIA, SHARON L · 2007 to 2009
$5.1M
GENETIC DETERMINANTS OF HIGH BP IN THREE RACIAL GROUPSU01HL054457 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KARDIA, SHARON L · 2000 to 2004
$2.8M
Genetics of Chronic Kidney DiseaseR01DK073537 · NIDDK · MAYO CLINIC ROCHESTER · PI TURNER, STEPHEN T · 2006 to 2010
$2.4M
Genetic Mechanisms of Arteriosclerosis in Hypertensive SibshipsR01HL119443 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KARDIA, SHARON L · 2014 to 2017
$2.1M
Genetic determinants of urine lithogenicityR01DK077950 · NIDDK · MAYO CLINIC ROCHESTER · PI LIESKE, JOHN C · 2008 to 2011
$1.8M
NCATS NIH HHS UL1 TR000135NHLBI NIH HHS R01 HL087660NHLBI NIH HHS R01 HL119443NHLBI NIH HHS U01 HL054457NIDDK NIH HHS P50 DK083007NIDDK NIH HHS R01 DK073537NIDDK NIH HHS R01 DK077950
6 · The paper itself

Abstract

objectivesThe urinary excretion of organic and inorganic substances and their concentrations have attracted extensive attention for their role in the pathogenesis of urinary stone disease. The urinary excretion of specific factors associates with sex and age and seems to have a hereditary component, but the precise genomic determinants remain ill-defined.

methodsGenome-wide association studies previously conducted in 3 cohorts (Genetic Epidemiology Network of Arteriopathy study, January 1, 2006, through December 31, 2012; the combined Nurses' Health Study (NHS), NHS II, and Health Professionals Follow-up Study, January 1, 1994, through December 31, 2003; and the Prevention of Renal and Vascular End-stage Disease study, January 1, 1997, through December 31, 1998) were combined into meta-analyses to evaluate genetic associations with available urinary phenotypes relevant to stone pathogenesis (calcium, magnesium, and uric acid excretion; total urine volume).

resultsOne region on chromosome 9q21.13 showed strong evidence of an association with urinary magnesium excretion. The strongest signal in this region was near

conclusionCommon variants near genes important for magnesium metabolism and bone health associate with urinary magnesium and calcium excretion.

Indexed as

BMI, body mass indexCKD, chronic kidney diseaseFGF23, fibroblast growth factor 23GDUL, Genetic Determinants of Urinary LithogenicityGENOA, Genetic Epidemiology Network of ArteriopathyGWAS, Genome-wide association studyHPFS, Health Professionals Follow-up StudyNHS, Nurses’ Health StudyPREVEND, Prevention of Renal and Vascular End-stage DiseaseQQ, quantile-quantileSNP, single nucleotide polymorphism

Identifiers

PMID31993563
PMCPMC6978610
OpenAlexW2990116344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.